Abstract:Group 2 innate lymphoid cells (ILC2s) were identified in 2010 as a novel lymphocyte subset lacking antigen receptors, such as T-cell or B-cell receptors. ILC2s induce local immune responses characterized by producing type 2 cytokines and play essential roles for maintaining tissue homeostasis. ILC2s are distributed across various organs, including the intestine where immune cells are continuously exposed to external antigens. Followed by luminal antigen stimulation, intestinal epithelial cells produce alarmins, such as IL-25, IL-33, and thymic stromal lymphopoietin, and activate ILC2s to expand and produce cytokines. In the context of parasite infection, the tuft cell lining in the epithelium has been revealed as a dominant source of intestinal IL-25 and possesses the capability to regulate ILC2 homeostasis. Neuronal systems also regulate ILC2s through neuropeptides and neurotransmitters, and interact with ILC2s bidirectionally, a process termed "neuro-immune crosstalk". Activated ILC2s produce type 2 cytokines, which contribute to epithelial barrier function, clearance of luminal antigens and tissue repair, while ILC2s are also involved in chronic inflammation and tissue fibrosis. Recent studies have shed light on the contribution of ILC2s to inflammatory bowel diseases, mainly comprising ulcerative colitis and Crohn's disease, as defined by chronic immune activation and inflammation. Modern single-cell analysis techniques provide a tissue-specific picture of ILC2s and their roles in regulating homeostasis in each organ. Particularly, single-cell analysis helps our understanding of the uniqueness and commonness of ILC2s across tissues and opens the novel research area of ILC2 heterogeneity. ILC2s are classified into different phenotypes depending on tissue and phase of inflammation, mainly inflammatory and natural ILC2 cells. ILC2s can also switch phenotype to ILC1- or ILC3-like subsets. Hence, recent studies have revealed the heterogeneity and plasticity of ILC2, which indicate dynamicity of inflammation and the immune system. In this review, we describe the regulatory mechanisms, function, and pathological roles of ILC2s in the intestine.

Group 2 Innate Lymphoid Cells Exhibit Tissue-Specific Dynamic Behaviour During Type 2 Immune Responses

Localization and site-specific cell-cell interactions of group 2 innate lymphoid cells

New insights into the function, development, and plasticity of type 2 innate lymphoid cells

Tissue-specific pathways extrude activated ILC2s to disseminate type 2 immunity

Innate lymphoid cells — how did we miss them?

ILC2s-Trailblazers in the Host Response Against Intestinal Helminths

Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology

Functions of Group 2 Innate Lymphoid Cells in Tumor Microenvironment

Innate Lymphoid Cells and Inflammatory Bowel Disease

ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses

Heterogeneity of Group 2 Innate Lymphoid Cells Defines Their Pleiotropic Roles in Cancer, Obesity, and Cardiovascular Diseases

Maturation and specialization of group 2 innate lymphoid cells through the lung-gut axis

S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense

The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms

Parallel origins and functions of T cells and ILCs

ILC2s navigate tissue redistribution during infection using stage-specific S1P receptors

Identification of Group 2 Innate Lymphoid Cells in Mouse Lung, Liver, Small Intestine, Bone Marrow, and Mediastinal and Mesenteric Lymph Nodes

Cooperation of ILC2s and TH2 cells in the expulsion of intestinal helminth parasites

Group 1 ILCs: Heterogeneity, plasticity, and transcriptional regulation

Identification of Two Migratory Colon ILC2 Populations Differentially Expressing IL-17A and IL-5/IL-13

New insights into ILC2 memory